Skip to main content
. 2021 Dec 30;100(52):e28424. doi: 10.1097/MD.0000000000028424

Table 1.

Demography of patients with and without RVO.

Variables RVO (n = 57) non-RVO (n = 125) P-value
Age, ya 76.8 (9.4) 75.6 (8.6) .783
Sex: Maleb 23 (40.4) 43 (34.4) .439
HTN, mm Hg
 SBPa 137.1 (17.7) 125.9 (13.2) <.001
 DBPa 72.7 (11.8) 65.6 (8.0) <.001
 120> and 80>b 8 (14.0) 38 (30.4)
 120 ≤ SBP < 140 or 80 ≤ DBP < 90b 25 (43.9) 62 (49.6) <.001∗∗
 140 ≤ SBP < 160 or 90 ≤ DBP < 100b 18 (31.6) 25 (20.0)
 SBP ≥ 160 or DBP ≥ 100b 6 (10.5) 0
TC, mg/dLa 203.4 (33.5) 203.8 (35.4) .468
LDL-C, mg/dLa 119.6 (29.9) 115.5 (27.3) .819
HDL-C, mg/dLa 55.0 (15.2) 59.1 (14.0) .039
Non-HDL-C, mg/dLa 148.4 (32.4) 144.7 (31.1) .135
BMI, kg/m2 a 22.5 (3.5) 23.0 (3.6) .180
eGFR (mL/min/1.73 m2)a 67.6 (23.7) 76.9 (22.8) .006
DMb 16 (28.1) 26 (20.8) .280∗∗
Alcohol intakeb 12 (21.1) 41 (32.8) .106∗∗
Smokingb 12 (21.1) 31 (24.8) .110∗∗
Medication
 Anticoagulantb 5 (8.8) 6 (4.8) .297∗∗
 Antiplatelet drugb 12 (21.1) 25 (20.0) .870∗∗
 Othersb 5 (8.8) 5 (4.0) .190∗∗
 Anti-VEGFc: number of times 0b 12 (21.1) 120 (96)
  1b 12 (21.1) 0 <.001∗∗
  2b 5 (8.8) 1 (0.8)
  ≥3b 28 (49.1) 4 (3.2)